Month: November 2019

Mylan tops profit estimates on drug launches

Generic drugmaker Mylan NV beat Wall Street estimates for third-quarter profit on Tuesday, benefiting from drug launches such as Wixela and Fulphila, sending its shares...
AKHBAR.ES
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.